EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 111 filers reported holding EPIZYME INC in Q2 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,888,000 | +22.5% | 272,476 | +56.6% | 0.54% | +17.8% |
| Q2 2018 | $2,357,000 | -4.1% | 173,982 | +25.7% | 0.46% | -0.2% |
| Q1 2018 | $2,457,000 | -4.3% | 138,431 | -32.3% | 0.46% | -14.3% |
| Q4 2017 | $2,568,000 | -29.7% | 204,600 | +6.7% | 0.53% | -47.6% |
| Q3 2017 | $3,652,000 | +57.7% | 191,719 | +25.0% | 1.02% | +48.5% |
| Q2 2017 | $2,316,000 | – | 153,351 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |